Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks

Published:2012-10 Issue:10 Volume:28 Page:1184-1195
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Aberg Judith A.¹,Tebas Pablo²,Overton Edgar Turner³,Gupta Samir K.⁴,Sax Paul E.⁵,Landay Alan⁶,Falcon Ron⁷,Ryan Robert⁸,De La Rosa Guy⁹

Affiliation:

1. Bellevue Hospital Center at New York University School of Medicine, New York, New York.

2. AIDS Clinical Trials Unit, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.

3. Washington University School of Medicine, St. Louis, Missouri.

4. Indiana University School of Medicine, Indianapolis, Indiana.

5. Division of Infectious Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

6. Rush University Medical Center, Chicago, Illinois.

7. Janssen Therapeutics, Titusville, New Jersey.

8. Janssen R&D, Titusville, New Jersey.

9. Janssen Global Services, Titusville, New Jersey.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2011.0327

Reference57 articles.

1. The role of HIV in serious diseases other than AIDS

2. Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

3. Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

4. The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications

5. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum uric acid and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy: a comparative cross-sectional study;Frontiers in Medicine;2024-07-17

2. Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas;Life;2024-03-28

3. Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIV;AIDS Research and Human Retroviruses;2022-09-01

4. The effect of protease inhibitors‐based antiretroviral therapy on serum/plasma interleukin‐6 levels among PLHIV: a systematic review and meta‐analysis;Journal of Medical Virology;2022-06-28

5. Comparison of the Efficacy and Safety of a Doravirine-Based, Three-Drug Regimen in Treatment-Naïve HIV-1 Positive Adults: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3